Study of patients with severe skin infections in the SURFAST care pathway
Part of Bones, joints & muscles clinical trials.
This study follows patients who have a serious infection of the skin and soft tissues (necrotizing soft-tissue infection) and are treated with a specific care plan called SURFAST. It aims to learn more about how this care approach works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a suspected or surgically confirmed necrotizing soft-tissue infection (a rare, severe infection that destroys skin and muscle).
- You (or your legal guardian) must agree to join the study and sign a consent form.
- You cannot have refused to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two wound care methods after emergency surgery for a serious skin infection. One method uses a standard wound vacuum, and the other uses a wound vacuum that also irrigates (rinses) the wound to see if it helps with healing.
This trial is for people under 18 who have a confirmed invasive Group A strep infection, meaning strep bacteria found in places that are normally sterile (like the blood or deep tissues). It tests whether a specific study approach can help improve outcomes for children with these serious infections.
This trial studies a rare but serious infection called necrotizing soft-tissue infection (NSTI), which destroys tissue quickly. It looks at how patients are treated in hospitals across Europe to improve care.
This study looks at what factors are linked to higher risk of death in patients hospitalized with a severe, flesh-eating infection called necrotizing soft tissue infection (NSTI). It aims to help doctors better identify and treat these dangerous infections.
This study compares a shorter course (about 7 days) of antibiotics to a longer course (about 14 days) for people who had surgery for a severe skin and muscle infection. The goal is to see if a shorter treatment works just as well.
This trial tests whether adding hyperbaric oxygen therapy to standard care helps adults with a serious soft-tissue infection. It could improve healing and reduce complications.
Hear when a new Necrotizing Soft-tissue Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.